What does QIAGEN offer for molecular diagnostics?
  • Oncology
    Learn more
    More and more oncology treatments require molecular evaluation of biomarkers for drug prescription. Find out about our therascreen diagnostic assays. Learn about QIAGEN technologies for mutation detection and other topics related to oncology and companion diagnostics.
  • Infectious Disease
    Learn more
    Discover more about our solutions for infectious disease, including integrated automated solutions on the QIAsymphony RGQ MDx (US).
  • Tuberculosis Management
    Learn more
    Discover more about our solution for the detection of tuberculosis infection – QuantiFERON-TB Gold. The assay measures cell-mediated immune responses by
    T-lymphocytes and correlates with a likelihood of infection.
  • Partnering for Precision Diagnostics
    Learn more on our experience 
    QIAGEN works in partnership with pharma companies to provide programs for companion diagnostic development and global commercialization.
  • Transplantation Testing
    Learn more
    Discover QIAGEN's FDA-approved assays for transplantation testing. Our CMV assay is one of only two FDA-approved tests for CMV.
  • Women's Health
    Learn more
    Prevention of disease is a huge focus of today's healthcare. QIAGEN offer products for the detection of human papillomavirus (HPV), Chlamydia trachomatis, and Neisseria gonorrhoeae alongside mid- to high-throughput automation. Validated sample collection, workflows, and automation provide standardized solutions for preventive testing.